Georgia Tech is proud to present Flashpoint, a startup accelerator program launching in August 2011. Flashpoint will provide mentorship, shared learning, office space, and an environment for accelerated scalable business model search.
Selected participants will typically be eligible for $15,000 in funding in exchange for up to 6% equity stake. Investments will be provided by the new Flashpoint Investment Fund headed by Sig Mosley of Imlay Investments.
Apply if you are:
- a team of at least two people with one or more ideas or a startup that has not yet reached the Series A funding stage of growth and
- in need of funding or are just interested in the accelerator program’s learning and guidance and
- utilizing technology as a competitive advantage in any market and
- can operate in Atlanta during the program.
Apply now to join our next cohort. We will run cohorts twice a year.
One of our primary goals in 2011 is to provide ATDC members with more educational and networking opportunities. An examples of the latter are our expanded CEO roundtables, the recently announced Entrepreneurs Night, and expanded Startup Circles. Today we are announcing the first in a series of educational programs that will be of great interest to technology startups.
Customer Connect is a unique concentrated five week program for technologist/founders of concept stage startups to help them begin interacting with customers early in the development of their company. Customer Connect utilizes coaching and peer groups to provide personalized learning for technology entrepreneurs. Program participants will develop an action plan to engage with customers, a positioning statement, market sizing data, and a product development plan.
The curriculum is a five week long program that takes place on Tuesday evenings from 5:00 – 7:00PM. Customer Connect will be offered five times over the course of 2011. The first session kicks off on January 18th and the participants have been identified. The next session starts March 1st and you can apply here to participate.
Despite the challenging times for bioscience funding, two ATDC companies successfully raised funds to complete clinical trials and expand footprint respectively.
CardioMEMS Inc., which is developing an implantable device to measure and transmit pulmonary artery pressure, has raised $37.9 million in additional capital. The funds give the Atlanta-based vendor capital to complete a clinical trial of its heart failure pressure management system, called CHAMPION, with 550 patients through 65 heart centers in the U.S. The trial started in 2007 with results expected this summer. The device is a wireless high-frequency sensor implanted in the artery using a catheter-based procedure based on proprietary technology from Georgia Tech. The pressure is measured and displayed on a monitoring system. Following the procedure, patients perform wireless measurements of the pulmonary artery pressure from home. The data is transmitted to a secure database for physician review on a proprietary Web site.
SoloHealth, Inc has raised $660,000 in additional capital. Founded in 2007, the company offers self-directed health-care services. Its first product, EyeSite, is an interactive, self-service, vision-testing kiosk that provides consumers with a free assessment of their vision, information about common eye health conditions and referrals to local eye care practitioners. As of March this year, SoloHealth had nearly 100 EyeSite kiosks in seven U.S. markets — including Atlanta ; Houston ; Richmond , Va. ; and Charlotte , N.C. — and will add three cities this year while enhancing the kiosks’ technology.
With ATDC’s expanded bioscience catalyst team we are available to work with all bioscience companies, from concept to market.